Ostermann M (2011) J CLI 35:10-12

Ostermann M (2011) J CLI 35:10-12

Neutrophil gelatinase-associated lipocalin (NGAL) has emerged as a promising biomarker for acute kidney injury (AKI). The ultimate goal is for NGAL to enable clinicians to intervene as early as possible and to change the prognosis of AKI. This article discusses the current position of NGAL in the race to become the "troponin of the kidney".

To download as pdf please click here